Draft:GeneGoCell
Submission declined on 14 July 2026 by Theroadislong (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Comment: completely fails WP:NCORP and blatant advertising. Theroadislong (talk) 07:21, 14 July 2026 (UTC)
Comment: In accordance with Wikipedia's Conflict of interest guideline, I disclose that I have a conflict of interest regarding the subject of this article. AaronZCGX (talk) 07:14, 14 July 2026 (UTC)
GeneGoCell is a San Diego-based biotechnology company specializing in customized next-generation sequencing (NGS) and flow cytometry services for the cell and gene therapy (CGT) industry. Founded in 2020, the company operates GxP- and CLIA-compliant laboratories accredited to ISO/IEC 17025:2017 standards and focuses on genome editing verification, genotoxicity testing, and precision analytics that support clients from early research through clinical development.
GeneGoCell provides fast-turnaround, fully customized solutions with an emphasis on regulatory compliance, data quality, and responsive project management. Its proprietary platforms include client information management systems (CIMS), laboratory information management systems (LIMS), and bioinformatics pipelines designed for sample-to-report workflows in the precision medicine sector.
The company is headquartered in the Rancho Bernardo area of San Diego, California, and maintains a team of 11–50 employees.
History
GeneGoCell Inc. was founded in November 2020 by Dr. Elizabeth Zhang to address the growing demand for rapid, high-quality, compliant testing services in the cell and gene therapy field. Zhang-Chen serves as Chief Executive Officer and brings expertise in immunology, quality management, and business (PhD in immunology from the University of Kansas Medical Center; MBA from UC San Diego’s Rady School of Management; certifications including SCYM(ASCP)CM and CMQ/OE).
The company was established to fill a market gap for fast, reliable genotoxicity and genome editing verification services that help accelerate regulatory approval while maintaining rigorous safety and quality standards.
Services
GeneGoCell offers end-to-end customized services centered on Next-Generation Sequencing (NGS) and Flow Cytometry, with particular strength in genome editing verification for CGT applications.
Genome Editing Verification (GEV℠)
- G-GUIDE℠: Optimized and licensed GUIDE-Seq service provider for genome-wide off-target identification.
- G-Amp℠: On-target and off-target editing verification.
- G-Trans℠: Translocation identification.
- G-Int℠: Integration loci identification, integration frequency and transgene integrity (long-reads sequencing).
- G-Screen℠: High-throughput cell clone genotyping.
Additional NGS Services
- Guide RNA (gRNA) sequencing
- RNA-Seq
- sgRNA screening
- PacBio sequencing
- Fully custom NGS assay development and bioinformatics
Flow Cytometry
Custom panel design, development, and analysis with compliant reporting.
The company emphasizes rapid turnaround (approximately 90% of NGS projects completed within one week and nearly all within two weeks, with expedited options as fast as three days), tailored assays/workflows, and dedicated project managers who provide responsive support.
Compliance and Quality Systems
GeneGoCell maintains GxP (GMP and GLP), CLIA compliance, and ISO/IEC 17025:2017 accreditation (with ANAB recognition). An experienced quality assurance team reviews all testing and analysis to support regulatory submissions and clinical-stage work. These credentials enable the company to serve clients pursuing IND-enabling studies and clinical trials in the cell and gene therapy space.
Proprietary informatics systems (CIMS, LIMS, and advanced bioinformatics pipelines) ensure traceability, data integrity, and efficient sample-to-report delivery.
Mission and Values
GeneGoCell’s stated mission is “To provide fast-turnaround, top-quality, customized services via innovating genomics and cellular technologies.” Its core values are summarized as Love | Trust | Commitment, which the company describes as the foundations of its operations and client partnerships.
External links
References
- GeneGoCell official website (genegocell.com) — company services, compliance, and GEV offerings.
- “Complementary Skills: The Secret Behind GeneGoCell’s Husband-and-Wife Leadership Duo,” ACA San Diego (acasandiego.org), 2024.
- LinkedIn Company Profile — GeneGoCell Inc.
- Crunchbase — GeneGoCell profile.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.

- provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.